• Exchange: Oslo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Navamedic ASA

+ Add to Watchlist

NAVA:NO

11.100 NOK 0.550 4.72%

As of 10:25:04 ET on 12/23/2014.

Snapshot for Navamedic ASA (NAVA)

Open: 11.450 Day's Range: 10.800 - 11.450 Volume: 36,167
Previous Close: 11.650 52wk Range: 10.450 - 16.300 1-Yr Rtn: -9.39%

Stock Chart for NAVA

No chart data available.
  • NAVA:NO 11.100
  • 1D
  • 1M
  • 1Y
11.650
Interactive NAVA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NAVA

Current P/E Ratio (ttm) 136.9407
Estimated P/E(12/2014) -
Relative P/E vs. OBX 11.8285
Earnings Per Share (NOK) (ttm) 0.0811
Est. EPS (NOK) (12/2014) -
Est. PEG Ratio -
Market Cap (M NOK) 95.04
Shares Outstanding (M) 8.56
30 Day Average Volume 9,117
Price/Book (mrq) 0.9201
Price/Sale (ttm) 0.4646
Dividend Indicated Gross Yield -%
Cash Dividend (NOK) -
Dividend Ex-Date 05/07/2012
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NAVA

  • Revenue
  • Net Income (M/NOK)
  • Profit Margin (%)

Company Profile & Key Executives for NAVA

Navamedic ASA is a pharmaceutical company focusing on the development and production of glucosamine HCl (hydrochloride) based medicines.

Hakan JosephssonInterim CEO/Head:Nordic OperationsBjorn LindholtChief Financial Officer
Per Anders ElvertroCCO/Head:Regulatory AffairsOlof MilvedenStrategic Advisor
More Company Profile & Key Executives for NAVA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil